𝔖 Bobbio Scriptorium
✦   LIBER   ✦

QS395. HMGB1 Release is Interferon Regulatory Factor-1 (IRF-1) Dependent in Endotoxemia

✍ Scribed by R. Dhupar; P. Pan; J. Cardinal; S.W. Cho; J.R. Klune; D.A. Geller; A. Tsung

Book ID
116705216
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
73 KB
Volume
151
Category
Article
ISSN
0022-4804

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Intratumoral interferon regulatory facto
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer
✍ Alain G. Zeimet; Daniel Reimer; Dominik Wolf; Heidi Fiegl; Nicole Concin; Annema πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 345 KB

## Abstract IRF‐1 and IRF‐2 expression was determined by real‐time PCR in 138 ovarian cancer samples and 30 healthy ovarian biopsies and was correlated with the expression of other relevant immunologic parameters and common clinicopathologic variables. Regulation of IRF‐1 and IRF‐2 was evaluated by

The ambiguous role of interferon regulat
The ambiguous role of interferon regulatory factor-1 (IRF-1) immunoexpression in myelodysplastic syndrome
✍ Ronald Feitosa Pinheiro; Konradin Metze; Maria Regina RΓ©gis Silva; Maria de Lour πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 161 KB

Recent investigations postulate a participation of the interferon regulatory factor-1 (IRF-1) in the development of myelodysplasia (MDS) and in the pathogenesis of autoimmune manifestations (AIMs) in patients with this disease. The aim of this prospective study was to compare the IRF-1 immunoexpress